AzTrials
AzTrials

Infrared-thermal-imagingNCT05830227

Evaluation of Infrared Thermal Imaging in Diagnosis of OSAHS in Children

An observational study of Infrared-thermal-imaging, run by State Key Laboratory of Respiratory Disease at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

OSAHS is a common sleep breathing disorder in children, with the same incidence as childhood asthma, and is mainly caused by upper airway stenosis caused by tonsil/adenoid hyperplasia. Read more about this study

Who is it for?
Ages 2 to 14 yearsHealthy volunteers can take part
Conditions the study is for
Infrared-thermal-imaging
How many people
80 participants
Where
1 siteChina
Study dates
Apr 2023to Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: -Children ages 2 to 14 with SDB related symptoms

Who may be able to join

  • Children ages 2 to 14 with SDB related symptoms

Who cannot join

  • 1) Congenital abnormalities of the nose and throat or airway;
  • 2) craniofacial deformity
  • 3) Neuromuscular dysregulation
  • 4) History of adenoids and/or tonsillectomy.

Trial locations and contacts

1 site in 1 country.

Lijun Z [lzeng], visiting staff contact

13450360939 ext. Lijun Zeng

865391757@qq.com

China1 site, 1 recruiting
  • Lijun Zeng [lzeng]

    Guangdong, Uangdong, 510000

    Lijun Z [lzeng], 13450360939 ext. Lijun Zeng, 865391757@qq.com

    Recruiting

Other trials in China

About this study

Official title: Evaluation of Infrared Thermal Imaging in Diagnosis of Obstructive Sleep Apnea Hypopnea Syndrome in Children

OSAHS is a common sleep breathing disorder in children, with the same incidence as childhood asthma, and is mainly caused by upper airway stenosis caused by tonsil/adenoid hyperplasia. Clinical findings show that children with OSAHS often present rhinitis symptoms and like rubbing eyes, but there is no evidence to suggest a correlation. Children with OSAHS suffer from recurrent hypoxemia during sleep, and the existing detection methods such as lateral nasopharyngeal radiographs and electronic nasopharyngoscopy can only reflect the structural and morphological changes of the oral, nasal and pharyngeal tissues, but cannot prove their functional status. Previous studies have found that infrared thermal imaging can reflect the oral, nasal and pharyngeal inflammation of patients, and the infrared expression of patients' frontal region and eyes can also reflect the physiological changes caused by sleep deprivation.

Read the detailed description

In this project, the children were divided into four groups: primary snoring, critical OSAHS, mild OSAHS and moderate to severe OSAHS, and the tests were completed, including lateral nasopharyngeal radiographs, infrared detection of oropharynx and pharynx, infrared detection of frontal area and eye area, intelligence and behavior scale assessment, etc. Furthermore, the correlation between infrared detection and obstructive sleep apnea hypopnea index, peripheral blood oxygen saturation, adenoid hyperplasia degree of nasopharyngeal lateral film as parameters were analyzed, and the sensitivity and specificity of infrared detection was determined to confirm the diagnostic value of OSAHS. It provides a theoretical basis for finding a convenient, non-damaging, non-radiation, visual and suitable for children functional image detection method.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05830227
Study groupRoleWhat they receive
Primary snoring groupPrimary snoring group
Critical OSAHS groupCritical OSAHS group
Mild OSAHS groupMild OSAHS group
Moderate to severe OSAHS groupModerate to severe OSAHS group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation between infrared expression of oral, nasal and pharyngeal inflammation and disease severity

    Correlation between infrared expression of oral, nasal and pharyngeal inflammation and disease severity (sleep breathing parameters OAHI and LSpO2)

    Measured: 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2023
  2. Study startApr 2023 (estimated)
  3. Primary completionApr 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05830227
Sponsor's protocol ID
GuangzhouIRD
Status last verified
Apr 2023
First submitted
14 Apr 2023
Last updated
26 Apr 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Observe and study before sharing

Questions about this trial

What is this clinical trial studying?

An observational study of Infrared-thermal-imaging, run by State Key Laboratory of Respiratory Disease at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lijun Z [lzeng], visiting staff (13450360939 ext. Lijun Zeng, 865391757@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation between infrared expression of oral, nasal and pharyngeal inflammation and disease severity (time frame: 2025). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in